Financial insights of XENE

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Collaboration revenue (note 8)	0	0	0	0
Research and development	88,508,000	87,699,000	77,054,000	74,985,000
General and administrative	23,820,000	22,068,000	19,282,000	19,244,000
Total operating expenses	112,328,000	109,767,000	96,336,000	94,229,000
Loss from operations	-112,328,000	-109,767,000	-96,336,000	-94,229,000
Interest income	6,907,000	5,340,000	6,206,000	7,199,000
Unrealized fair value gain on trading securities	-	0	-	-
Foreign exchange loss	548,000	-296,000	-89,000	1,698,000
Total other income	7,455,000	5,044,000	6,117,000	8,897,000
Loss before income taxes	-104,873,000	-104,723,000	-90,219,000	-85,332,000
Income tax recovery (expense)	-2,571,000	538,000	677,000	-626,000
Net loss	-102,302,000	-105,261,000	-90,896,000	-84,706,000
Unrealized gain (loss) on available-for-sale securities (note 4)	-1,546,000	-	364,000	949,000
Comprehensive loss	-103,848,000	-	-90,532,000	-83,757,000

Basic EPS	-1.17	-1.34	-1.15	-1.07
Diluted EPS	-1.17	-1.34	-1.15	-1.07
Basic Average Shares	87,345,717	80,126,080	79,247,976	78,953,445
Diluted Average Shares	87,345,717	80,126,080	79,247,976	78,953,445